About Us

About Komen Greater Detroit Affiliate®

The Komen Greater Detroit Affiliate was established as a 501c3 in 2016 after separation from the Barbara Ann Karmanos Cancer Institute who started the Komen Detroit Race for the Cure event in 1992. The inaugural Board of Directors was formed to build the framework of a $1 million –plus revenue generating Affiliate within the Susan G. Komen Affiliate Network poised to expand Komen’s work throughout Southeast Michigan.

About Susan G. Komen®

In 1980, Nancy G. Brinker promised her dying sister, Susan, that she would do everything in her power to end breast cancer forever. In 1982 that promise became the Susan G. Komen® organization, and the beginning of a global movement. What was started with $200 and a shoebox full of potential donor names has now grown into the world’s largest nonprofit source of funding for the fight against breast cancer. To date, we’ve invested more than $2.6 billion in groundbreaking research, community health outreach, advocacy and programs in more than 60 countries. Our efforts helped reduce death rates from breast cancer by 37 percent, between 1990-2013, and we won’t stop until our promise is fulfilled.

About Komen Detroit Race for the Cure®

The Komen Detroit Race for the Cure (RFTC) was established in 1992 in partnership with the Michigan Cancer Foundation, now the Barbara Ann Karmanos Cancer Institute. The Karmanos Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, and has always served as the Komen Detroit RFTC Local Presenting Sponsor. Since the first Detroit Race in 1992, more than $29 million has been raised and invested in the fight against breast cancer consistent with Susan G. Komen’s formula of 25 percent of net proceeds dedicated to Komen’s research grant program, and the remaining 75 percent invested into local community grants supporting screening, treatment support and education for underserved communities. Since 1992, approximately $15,187,500 has been invested into local community grants.